Literature DB >> 33628807

Effects of Bisphosphonates on Osseointegration of Dental Implants in Rabbit Model.

Ru Qing Yu1, Jing Yi Wang1, Nian Jing Rao1, Lei Huo1, Li Wu Zheng1.   

Abstract

This study is to investigate the effect of bisphosphonates on the osseointegration of dental implants in a rabbit model. Twenty female New Zealand White rabbits were equally assigned into control and experiment groups which received saline or zoledronic acid treatment 4 weeks prior to surgery. Titanium dental implant was placed on the calvarial bone. Zoledronic acid or saline treatment continued after surgery for 4 weeks (short-term subgroup) or 8 weeks (long-term subgroup) until sacrifice. Three different fluorochrome labeling solutions were administrated for assessing bone growth rates. Samples of the calvarial bone and mandible were subjected to microcomputed tomography (micro-CT), confocal microscope, and histology analysis. Zoledronic acid treatment significantly reduced bone growth rates in the calvarial bone, but had no significant influence in bone mineral density and trabecular microarchitecture. Significantly lower bone-to-implant contact ratios were found in zoledronic acid-treated animals compared to controls at week 4 but not at week 8. Oncologic dose zoledronic acid suppresses the bone growth rates of the calvarial bone; ZA may have an adverse effect on osseointegration of dental implant in short term, but this effect tends to diminish in long term.
Copyright © 2021 Ru Qing Yu et al.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33628807      PMCID: PMC7895577          DOI: 10.1155/2021/6689564

Source DB:  PubMed          Journal:  Biomed Res Int            Impact factor:   3.411


  40 in total

1.  Skeletal benefits of alendronate: 7-year treatment of postmenopausal osteoporotic women. Phase III Osteoporosis Treatment Study Group.

Authors:  R P Tonino; P J Meunier; R Emkey; J A Rodriguez-Portales; C J Menkes; R D Wasnich; H G Bone; A C Santora; M Wu; R Desai; P D Ross
Journal:  J Clin Endocrinol Metab       Date:  2000-09       Impact factor: 5.958

Review 2.  Success criteria in implant dentistry: a systematic review.

Authors:  P Papaspyridakos; C-J Chen; M Singh; H-P Weber; G O Gallucci
Journal:  J Dent Res       Date:  2011-12-08       Impact factor: 6.116

3.  Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee.

Authors:  A M Parfitt; M K Drezner; F H Glorieux; J A Kanis; H Malluche; P J Meunier; S M Ott; R R Recker
Journal:  J Bone Miner Res       Date:  1987-12       Impact factor: 6.741

4.  Bone filling around titanium implants may benefit from smoking cessation: a histologic study in rats.

Authors:  João B César-Neto; Bruno B Benatti; Enilson A Sallum; Antonio W Sallum; Francisco H Nociti
Journal:  J Periodontol       Date:  2005-09       Impact factor: 6.993

5.  Changes in bone histomorphometry after long-term treatment with intermittent, cyclic etidronate for postmenopausal osteoporosis.

Authors:  T Storm; T Steiniche; G Thamsborg; F Melsen
Journal:  J Bone Miner Res       Date:  1993-02       Impact factor: 6.741

6.  Selective cyclooxygenase-2 inhibitor may impair bone healing around titanium implants in rats.

Authors:  Fernanda V Ribeiro; João B César-Neto; Francisco H Nociti; Enilson A Sallum; Antonio W Sallum; Sérgio De Toledo; Márcio Z Casati
Journal:  J Periodontol       Date:  2006-10       Impact factor: 6.993

7.  Prevention of osteocyte and osteoblast apoptosis by bisphosphonates and calcitonin.

Authors:  L I Plotkin; R S Weinstein; A M Parfitt; P K Roberson; S C Manolagas; T Bellido
Journal:  J Clin Invest       Date:  1999-11       Impact factor: 14.808

8.  Early healing of hydroxyapatite-coated implants in grafted bone of zoledronic acid-treated osteoporotic rabbits.

Authors:  Jian-Ping Li; Peng Li; Jing Hu; Wei Dong; Nan-Nan Liao; Meng-Chun Qi; Jin-Yuan Li
Journal:  J Periodontol       Date:  2013-05-20       Impact factor: 6.993

9.  Alendronate mechanism of action: geranylgeraniol, an intermediate in the mevalonate pathway, prevents inhibition of osteoclast formation, bone resorption, and kinase activation in vitro.

Authors:  J E Fisher; M J Rogers; J M Halasy; S P Luckman; D E Hughes; P J Masarachia; G Wesolowski; R G Russell; G A Rodan; A A Reszka
Journal:  Proc Natl Acad Sci U S A       Date:  1999-01-05       Impact factor: 11.205

10.  The effect of antiresorptive drugs on implant therapy: Systematic review and meta-analysis.

Authors:  Andreas Stavropoulos; Kristina Bertl; Peter Pietschmann; Nikolaos Pandis; Morten Schiødt; Björn Klinge
Journal:  Clin Oral Implants Res       Date:  2018-10       Impact factor: 5.977

View more
  1 in total

1.  Effects of Soft Tissue Closure on Medication-Related Osteonecrosis of the Jaw in a Rabbit Model with Tooth Extraction: A Pilot Study.

Authors:  Ru Qing Yu; Jing Wen Li; Jing Yi Wang; Lei Huo; Li Wu Zheng
Journal:  Biomed Res Int       Date:  2021-12-15       Impact factor: 3.411

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.